What other reason could there be for trial data being late?
If the trial data is bad, it is considered material and something that the market should be informed of immediately in the spirit of continuous disclosure.
So to my mind if the trial data is taking longer than expected it is because the patients are lasting longer than expected
Ann: Change in substantial holding, page-37
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)